B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report

China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：145
  • REPORT CODE：GMM1786414
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the B-Cell Maturation Antigen (BCMA) Targeted Therapies industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Juno Therapeutics

    • Deerfield Partners

    • Onyx Pharmaceuticals

    • Eureka Therapeutics

    • Transposagen Biopharmaceuticals

    • Sutro Biopharma

    • Credit Suisse Securities

    • Dana-Farber Cancer Institute

    • Five Prime Therapeutics

    By Type:

    • Bispecific Antibodies

    • Chimeric Antigen Receptor T-Cells

    • Antibody Drug Conjugates

    By Application:

    • Others

    • Brain Cancer

    • Liver Cancer

    • Respiratory Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Overview 2018-2029

    • 1.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Development Overview

    • 1.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Development History

    • 1.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Market Size (2018-2029)

    • 1.4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis by Type from Production Side

      • 1.4.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Bispecific Antibodies (2018-2029)

      • 1.4.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Chimeric Antigen Receptor T-Cells (2018-2029)

      • 1.4.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Antibody Drug Conjugates (2018-2029)

    • 1.5 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis by Application from Consumption End

      • 1.5.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Brain Cancer (2018-2029)

      • 1.5.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Liver Cancer (2018-2029)

      • 1.5.4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Respiratory Cancer (2018-2029)

    • 1.6 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis by Region

      • 1.6.1 North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    Chapter 2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Status and Competition at home and abroad in 2023

      • 2.2.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Status and Competition Analysis in 2023

      • 2.2.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Development

    Chapter 3 B-Cell Maturation Antigen (BCMA) Targeted TherapiesIndustry Chain Analysis

    • 3.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Chain

    • 3.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the B-Cell Maturation Antigen (BCMA) Targeted Therapies Market

    • 3.3 B-Cell Maturation Antigen (BCMA) Targeted Therapies Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the B-Cell Maturation Antigen (BCMA) Targeted Therapies Market

    Chapter 4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 4.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Total Production Volume and Growth Rate from Production Side

    • 4.5 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate, by Type

      • 4.5.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Bispecific Antibodies

      • 4.5.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Chimeric Antigen Receptor T-Cells

      • 4.5.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Antibody Drug Conjugates

    Chapter 5 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Total Market Size and Growth Rate from Consumption End

    • 5.5 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate, by Application

      • 5.5.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Others

      • 5.5.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Brain Cancer

      • 5.5.3 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Liver Cancer

      • 5.5.4 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Respiratory Cancer

    Chapter 6 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Region

    • 6.1 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Production Value, by Region

    • 6.2 China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume and Sales Value, by Region

    Chapter 7 North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 7.1 North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 7.2 North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 8 Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 8.1 Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 8.2 Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 9 South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 9.1 South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 9.2 South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 10 East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 10.1 East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 10.2 East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 11 Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 11.1 Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 11.2 Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 12 Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 12.1 Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 12.2 Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 13 Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Analysis

    • 13.1 Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Type

    • 13.2 Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Juno Therapeutics

        • 14.1.1 Juno Therapeutics Company Profile

        • 14.1.2 Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Deerfield Partners

        • 14.2.1 Deerfield Partners Company Profile

        • 14.2.2 Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Onyx Pharmaceuticals

        • 14.3.1 Onyx Pharmaceuticals Company Profile

        • 14.3.2 Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Eureka Therapeutics

        • 14.4.1 Eureka Therapeutics Company Profile

        • 14.4.2 Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Transposagen Biopharmaceuticals

        • 14.5.1 Transposagen Biopharmaceuticals Company Profile

        • 14.5.2 Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sutro Biopharma

        • 14.6.1 Sutro Biopharma Company Profile

        • 14.6.2 Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Credit Suisse Securities

        • 14.7.1 Credit Suisse Securities Company Profile

        • 14.7.2 Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Dana-Farber Cancer Institute

        • 14.8.1 Dana-Farber Cancer Institute Company Profile

        • 14.8.2 Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Five Prime Therapeutics

        • 14.9.1 Five Prime Therapeutics Company Profile

        • 14.9.2 Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Research Conclusions

    • 15.2 B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Market Size (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Bispecific Antibodies (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Chimeric Antigen Receptor T-Cells (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume, Production Value and Growth Rate of Antibody Drug Conjugates (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Brain Cancer (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Liver Cancer (2018-2029)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume, Sales Value and Growth Rate of Respiratory Cancer (2018-2029)

    • Figure North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate from 2018-2029

    • Figure B-Cell Maturation Antigen (BCMA) Targeted Therapies Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Share by Type in 2018

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Share by Type in 2023

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Bispecific Antibodies (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Chimeric Antigen Receptor T-Cells (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume and Growth Rate of Antibody Drug Conjugates (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Share by Application in 2018

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Share by Application in 2023

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Total Market Size and Growth Rate from Consumption End

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Others (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Brain Cancer (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Liver Cancer (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Size and Growth Rate of Respiratory Cancer (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Region (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Value by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Value Share by Region (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Value Share by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Region (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Value by Region (2018-2023)

    • Table China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Value Share by Region (2018-2023)

    • Figure China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Value Share by Region (2018-2023)

    • Table North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure North China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure Central China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure South China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure East China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure Northeast China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure Southwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume by Type (2018-2023)

    • Table Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Figure Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Production Volume Share by Type (2018-2023)

    • Table Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume by Application (2018-2023)

    • Table Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Figure Northwest China B-Cell Maturation Antigen (BCMA) Targeted Therapies Sales Volume Share by Application (2018-2023)

    • Table Juno Therapeutics Company Profile

    • Table Juno Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Deerfield Partners Company Profile

    • Table Deerfield Partners B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Onyx Pharmaceuticals Company Profile

    • Table Onyx Pharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Eureka Therapeutics Company Profile

    • Table Eureka Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Transposagen Biopharmaceuticals Company Profile

    • Table Transposagen Biopharmaceuticals B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Sutro Biopharma Company Profile

    • Table Sutro Biopharma B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Credit Suisse Securities Company Profile

    • Table Credit Suisse Securities B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Dana-Farber Cancer Institute Company Profile

    • Table Dana-Farber Cancer Institute B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)

    • Table Five Prime Therapeutics Company Profile

    • Table Five Prime Therapeutics B-Cell Maturation Antigen (BCMA) Targeted Therapies Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US